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Recent developments in hybridoma technology and T  cell cloning have per- 
mitted more precise study of human T  cell differentiation. Monocional antibodies 
have revealed several cell surface antigens that are important not only as T  cell 
differentiation markers but also as T  cell function-associated structures (I-4). 
One of these antigens, Leu-2 (T8), has been suggested to serve as a receptor for 
human class  I  major histocompatibility complex (MHC) l  molecules (1,  4).  Bio- 
chemical analysis of this molecule has revealed a  unique structure.  Leu-2  (T8) 
has been  reported to be a  heterodimer when isolated from thymocytes (5,  6), 
but a  homodimer when isolated from perpherial  blood T  cells or from  HPB- 
ALL cells (7, 8). 
Consistent with these observations, our recent study demonstrated the homo- 
dimeric form of the  Leu-2  (T8)  antigen on  HPB-ALL cells (9).  We also have 
reported the development of enzyme-linked immunosorbent assays (ELISA) for 
the detection of the  Leu-1,  Leu-2, and  Leu-3  antigens in their soluble forms. 
Using these assays, we have found that one antigen,  Leu-2, is specifically and 
spontaneously  released  from  T  cells.  The  preliminary  study  comparing  the 
released form of Leu-2 (RLeu-2) to the cellular form of Leu-2 (CLeu-2) led us 
to  the  conclusion  that  a  27,000-mol  wt  single  chain  form  of Leu-2  antigen 
carrying only one Leu-2a determinant was released from Leu-2 positive T  cells. 
Since RLeu-2 has unique characteristics, as compared with CLeu-2, and since 
Leu-2 has been thought to be an important molecule in cellular interaction and 
MHC restriction, further study of the biological and immunochemical nature of 
this release was appropriate.  In this report  we describe the immmunochemical 
analysis of RLeu-2. We show that RLeu-2 and CLeu-2 are structurally related 
and that the released form is derived directly from the cell surface. 
Materials and Methods 
Monoclonal  Antibodies.  The  mouse monoclonal anti-Leu-2a and anti-Leu-2b have 
been described previously (2). Purified preparations of these antibodies were obtained 
from Becton Dickinson, Mountain View, CA. Other monoclonal antibodies, 1D 12 (mouse 
IgG 1 anti-human mu chain) and L243 (mouse IgG2a anti-HLA-DR), were used as controls. 
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Biosynthetic Labeling of HPB-ALL Cells.  HPB-ALL cells were washed three times with 
phosphate-buffered saline (PBS).  1-2 ×  10  s cells were then suspended in 50 ml of RPMI 
medium lacking tyrosine, leucine, and phenylalanine, and supplemented with 5% dialyzed 
fetal calf serum (FCS); and incubated for 45 min at 37 °C to deplete pools of intracellular 
amino acids. Then [SH]tyrosine, [SH]leucine, and [3H]phenylalanine (1  mCi each) (New 
England Nuclear, Boston, MA) were added to the culture and the cells were incubated 
for  20  b  at  37°C  in  5%  CO~.  After  incubation,  the  supernatant  was  collected  by 
centrifugation.  Phenylmethylsulfonylfluoride (PMSF)  (Sigma  Chemical  Co.,  St.  Louis, 
MO) was added at a concentration of 1 mM. Pelleted cells were washed three times with 
PBS and a cell lysate was made with Nonidet P-40 (NP-40) as described previously (9). 
Cell Surface Radioiodination and Incubation of Radiolabeled Cells.  HPB-ALL cells were 
labeled with Na~SI (Amersham, Arlington Heights, IL), I  mCi per 1 ×  107 cells, by the 
lactoperoxidase method (10).  After washing the radiolabeled cells once with PBS, viable 
cells were collected by Ficoll-Hypaque gradient centrifugation. The viable cells at the 
interface were washed three times with  PBS and resuspended in  RPMI-1640  medium 
supplemented with 15% FCS, penicillin-streptomycin (20 ml of medium per 1 x  107 cells) 
and  incubated  for  18  h  at  37°C.  After incubation,  supernatant  and  cell  lysate were 
prepared as described above. 
Immunoprecipitation and Gel Electrophoresis.  Before specific immunoprecipitation, the 
samples were precleared by incubation with an irrelevant mouse IgGl coupled to Sepha- 
rose  4B  beads  (Pharmacia,  Uppsala,  Sweden) at  4°C.  After  removing the  beads  by 
centrifugation, the samples were divided into aliquots and specific monocional antibody- 
coupled Sepharose 4B beads (25 t~l of packed wet volume containing 25 #g of antibody) 
were added and incubated at 4°C. The beads were then washed four times with 0.2 M 
Tris-HCi, pH 8.0, 0.5 M NaCI, 0.5% NP-40, 0.2 mM PMSF buffer. In the immunopre- 
cipitations where anti-Leu-2b was  used,  25 #g of anti-Leu-2b and 25 #! of Protein A- 
coupled Sepharose beads (Pharmacia) were added to the sample at the same time and 
were incubated in the same manner described above. Immunoprecipitated materials were 
eluted from the beads with either SDS sample buffer with 2-mercaptoethanol (2ME) (11) 
or with isoelectric focusing sample buffer with 2ME (12), and analyzed either by one- 
dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) or by 
two-dimensional gel techniques using non-equilibrium pH gel electrophoresis and SDS- 
PAGE. 
Peptide Mapping Analysis.  Peptide mapping analysis on one-dimensionaI SDS-PAGE 
was performed according to the method described by Cleveland et al. (13). Metabolically 
labeled or radioiodinated CLeu-2 and RLeu-2 were digested with Staphylococcus aureus 
V8 protease (Miles Laboratories, Elkhart, IN) at a concentration of 50 #g per ml (100 #1 
of each sample) and fragments analyzed on a  15% polyacrylamide gel. 
Results 
Molecular  Weight of RLeu-2.  In  our previous experiments (9),  we estimated 
the molecular weight of RLeu-2 to be 27,000 by iodination of the molecule after 
affinity isolation. We used two other methods to confirm the mol wt of RLeu-2; 
metabolic labeling and cell surface radioiodination preceding cell culture. With 
respect  to  metabolic  labeling,  HPB-ALL  cells  were  labeled  with  radioactive 
amino acids overnight. Cell viability was >90% after incubation. Both the culture 
supernatant and the cell lysate were subjected to immunoprecipitation. As shown 
in Fig.  1, a specific band of 27,000 mol wt was identified in the Leu-2 precipitate 
made from the culture supernatant (lane C), whereas a  33,000 tool wt band was 
seen in the Leu-2 precipitate from cell lysate (lane A). 
Following cell  surface  radioiodination,  HPB-ALL cells  were  cultured  over- 
night.  After incubation,  cell viability was >95%.  Both the  culture supernatant 
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FIGURE  1.  Spontaneous release of the metabolically labeled Leu-2 antigen from HPB-ALL 
cells. Antigen was immunoprecipitated  from either metabolically labeled HPB-ALL cell lysate 
(A and B) or from culture  supernatant  (C and D), and analyzed on 10% SDS-PAGE under 
reducing  conditions.  Anti-Leu-2a Sepharose 4B beads (A and C) and  1D12-Sepharose 4B 
beads (B and D) were used for immunoprecipitations. 
FICuRE 2.  Spontaneous release of the cell surface radiolabeled  Leu-2 antigen  from HPB- 
ALL cells. Antigen was immunoprecipitated from either cell surface radioiodinated HPB-ALL 
cell lysate (A and B) or from culture supernatant  (C and D) and analyzed on 10% SDS-PAGE 
under reducing conditions. Radioiodinated cell lysate prepared after incubation (E and F) was 
also analyzed. Immunoprecipitations  were performed with anti-Leu-2a-Sepharose  4B beads 
(A, C and E) and 1D12-Sepharose 4B beads (B, D, and F). 
noprecipitation.  Fig.  2  shows that a  27,000-mol  wt Leu-2 chain accumulated  in 
the  supernatant  (lane  C).  Leu-2  antigen  precipitated  from cell  lysates prepared 
before  incubation  appeared as  a  33,000-mol  wt polypeptide  chain  as  was  seen 
previously (Fig. 2A) (9). Residual intact cellular Leu-2 was found in the cell lysate 
prepared  after  incubation  (Fig.  2E),  but  in  reduced  quantity.  In  experiments 
where anti-Leu-1  or anti-Leu-3a beads were used in control immunoprecipita- 
tions  from  the  supernatant,  no  observable  band  was  seen  for  either  Leu-1  or 
Leu-3  antigen  (data  not  shown).  Therefore,  it  is  unlikely  that  the  radioactive 
Leu-2  antigen  in  the  supernatant  was  derived  from  dead  cells,  These  two 
experiments  indicated  that  RLeu-2  antigen  found  in  the  supernatant  of HPB- 
ALL is derived directly and specifically from CLeu-2 on the cell surface. 
RLeu-2 and  CLeu-2 Have Different Appearances  in  Two-dimensional  Gel Analy- 
sis.  RLeu-2  and  CLeu-2  were compared by two-dimensional  gel analysis (Fig. 
3). CLeu-2 appeared as a  smear in a  wide range of pH, although the majority of 
it was distributed in the basic area (Fig. 3 A). On the other hand, RLeu-2 appeared FUJIMOTO  ET  AL.  119 
FIGURE 3.  Two-dimensional analysis  of CLeu-2  and  RLeu-2.  Radioiodinated cell surface 
Leu-2 (A) and released Leu-2 (B) were precipitated by anti-Leu-2a Sepharose 4B and were 
analyzed by reducing two-dimensional gel analysis (nonequilibrium pH gel electrophoresis  and 
10% SDS-PAGE). 
as several distinct spots in the more acidic area showing less charge heterogeneity 
than CLeu-2 (Fig. 3B). 
RLeu-2 and CLeu-2 Share More Than One Antigenic Determinant.  Our previous 
results have demonstrated that RLeu-2 and CLeu-2 share the Leu-2a determi- 
nant. Since RLeu-2 and CLeu-2 had quite different immunochemical character- 
istics, it was important to know whether simple cross-reactivity accounted for the 
anti-Leu2a  binding to  RLeu-2.  At  least  two different antigenic determinants, 
Leu-2a and Leu-2b, have been identified on the Leu-2 molecule by monocional 
antibodies.  Possession of both the Leu-2a and Leu-2b determinants by RLeu-2 
would  make  unrelated  cross-reactivity  of the  RLeu-2  and  CLeu-2  molecules 
highly unlikely. Using anti-Leu-2a and anti-Leu-2b,  we explored the antigenic 
makeup of RLeu-2 and  CLeu-2.  Fig.  4-1  demonstrates that both anti-Leu-2a 
(lane A) and anti-Leu-2b  (lane  C) precipitated  the CLeu-2.  Similarly,  Fig.  4-2 
shows  that  both  anti-Leu-2a  (lane  A)  and  anti-Leu-2b  (lane  C)  precipitated 
RLeu-2, suggesting that RLeu-2 contained both antigenic determinants. RLeu- 
2  possession of both  Leu-2a and  Leu-2b epitopes was confirmed by sequential 
immunoprecipitation experiments.  Pretreatment  of RLeu-2-containing  super- 
natant with anti-Leu-2a  totally removed all  material  immunoreactive not only 
with anti-Leu-2a (Fig. 4-2, lane E) but also with anti-Leu-2b (Fig. 4-2, lane F). 
Pretreatment  of the  supernatant  with  a  class-matched  irrelevant  monoclonal 
antibody removed neither the anti-Leu  2a (Fig. 4-2, lane G) nor the anti-Leu- 
2b (Fig.  4-2,  lane H) immunoprecipitable material.  Therefore,  the Leu-2a and 
Leu-2b antigenic determinants co-exist on the single polypeptide chain of RLeu- 
2. 
Peptide Mapping Analysis of  RLeu-2 and CLeu-2.  Futher structural comparison 
was  made by peptide analysis  following limited proteolysis (Fig.  5).  Radioiodi- 
nated RLeu-2 and CLeu-2 were cleaved into their peptide fragments by Staphy- 
lococcus aureus  V8  protease  and  those  fragments  were  analyzed  on  a  15% 
polyacrylamide gel.  CLeu-2  (Fig.  5A) and  RLeu-2  (Fig.  5B) produced almost 120  IMMUNOCHEMICAL  ANALYSIS  OF  RELEASED LEU-2 
FIGURE 4.  Sequential immunoprecipitation  analysis of CLeu-2 (4-1) and RLeu-2 (4-2). Ra- 
dioiodinated  Leu-2 antigens were precipitated  by anti-Leu 2a Sepharose 4B beads (A) or by 
anti-Leu-2b-Protein-A  Sepharose 4B beads (C) from radioiodinated cell lysates (4-1) or from 
culture supernatants (4-2)  of HPB-ALL cells. For sequential immunoprecipitation experiments, 
cell lysates or culture  supernatants  were precleared  by either anti-Leu-2a Sepharose 4B (E 
and F) or 1D12 Sepharose 4B (G and H). The residual materials were divided into aliquots 
and were used for the next immunoprecipitations  with anti-Leu-2a Sepharose 4B (E and G) 
or with anti-Leu-2b-Protein  A Sepharose 4B (F and H).  1D12 Sepharose 4B (B) and L243- 
Protein-A-Sepharose 4 (D) were used as controls for anti-Leu-2a Sepharose 4B and anti-Leu- 
2b Protein-A Sepharose, respectively. 
identical  peptide  maps,  suggesting  significant  homology  between  RLeu-2  and 
CLeu-2.  A  peptide map of CLeu-2 metabolically labeled with  three radioactive 
amino acids was made to examine whether  new  fragments would  be produced. 
As  is  shown  in  Fig.  5C,  metabolically  labeled  CLeu-2  produced  peptide  frag- 
ments, identical  to those of radioiodinated  RLeu-2 and CLeu-2,  indicating  that 
all  the  fragments had  been  identified  by  125I tyrosine  labeling and  confirming 
the structural  homology of the two forms of the Leu-2 antigen. 
Discussion 
In an earlier study (9),  we discovered the  Leu-2  molecule in supernatants  of 
cells bearing  Leu-2 on  their surfaces.  We demonstrated  that the released  form 
of  Leu-2  (RLeu-2)  and  the  cellular  form  of  Leu-2  (CLeu-2)  had  different 
structures.  First,  RLeu-2  had  a  single  Leu-2a  determinant,  while  CLeu-2  had 
two or more Leu-2a determinants. Secondly, radioiodinated RLeu-2 was a single 
polypeptide  chain  of  27,000  mol  wt  under  both  reducing  and  nonreducing 
conditions, while radioiodinated CLeu-2 was a  homodimeric structure consisting FUJIMOTO ET  AL.  121 
FIGURE .5.  Peptide mapping analysis of CLeu-2 and  RLeu-2. Radioiodinated CLeu-2 (A) 
RLeu-2 (B) were digested with  Staphylococcus aureus V8 protease and analyzed on 15% SDS- 
PAGE. Peptide mapping of metabolically  labeled CLeu-2 (C) was also shown for comparison. 
of disulfide-linked  33,000-mol  wt subunits,  The  results  reported  here  further 
extend the comparison of RLeu-2 and CLeu-2. 
RLeu-2 and  CLeu-2 are similar  in  several respects.  First,  they share at  least 
two,  and  probably  more,  antigenic  determinants,  as  demonstrated  by similar 
detection  in  Leu-2  ELISA  and  depletion  in  sequential  immunoprecipitation 
studies. Secondly, RLeu-2 is a product of CLeu-2. In biosynthetic labeling studies, 
RLeu-2 appearance in cell supernatant  was accompanied by decreasing amounts 
of CLeu-2 (unpublished observations). In studies where viable cells were surface- 
radioiodinated  and  then  incubated overnight,  RLeu-2 appeared spontaneously 
in  the  culture  supernatant.  These  studies  confirmed  that  RLeu-2  was  not  an 
artefact of the previously used labeling or isolation procedures.  Finally, peptide 
maps of RLeu-2 and CLeu-2 demonstrated  marked similarity, suggesting struc- 
tural homology between the two species. 
RLeu-2 and  CLeu-2 also possess interesting  differences.  In  two-dimensional 
gel  analysis,  CLeu-2  and  RLeu-2  showed  quite  different  patterns.  Although 
CLeu-2 appeared as a smear over a  wide range of pH of which the major part 
was in the basic portion of the gel, RLeu-2 appeared as several spots having less 
charge heterogeneity in the more acidic portion. 
Lyt2-Lyt3,  the  Leu-2  homologous  structure  in  the  mouse  (14),  has  been 
characterized  by many  investigators.  In  many cases Lyt2-Lyt3 was found as a 
dimer or a tetramer bound by disulfide bonds (15-18).  However, a few reports 
suggested  the  presence  of the  free single  chain  of Lyt-2-Lyt-3 antigen  under 
nonreducing  conditions  (19,  20).  Like  Lyt-2-Lyt-3,  Leu-2  (T8)  has  subunits 
joined  by disulfide  bonds  (5-9).  Under  reducing  conditions,  Leu-2  from  thy- 
mocytes separates  into  two subunits  of 43,000  and  32,000  tool  wt  (5).  From 122  IMMUNOCHEMICAL  ANALYSIS  OF  RELEASED  LEU-2 
HPB-ALL cells, only the  33,000  (7-9) mol wt chain  has been identified using 
anti-Leu-2a,  OKT5, or OKT8. Under nonreducing conditions, no free subunit 
of Leu-2  (T8)  has  been  identified.  In  our studies,  cell  surface radioiodinated 
Leu-2  and  metabolically labeled  Leu-2  from  HPB-ALL cells showed identical 
two-dimensional  gel  patterns.  Furthermore,  no  free  subunit  of metabolically 
labeled Leu-2 was found under  nonreducing  conditions (unpublished observa- 
tions). Therefore, on HPB-ALL cells it is likely that Leu-2 antigen is composed 
of identical  disulfide chains  bonded to each  other and  that  no free subunit  is 
present. 
RLeu-2  is  a  single  chain  and  has  a  mol  wt  of 27,000.  It  appears  to  arise 
spontaneously  from  CLeu-2  by some  mechanism  intrinsic  to  the  lymphocyte. 
Production  of single  chains  from  a  disulfide-bonded  macromolecule  requires 
either  reduction  of the disulfide bonds or cleavage of the peptide at a  specific 
site.  Since  Leu-2  (T8)  has  a  membranous  hydrophobic portion  (8),  it  may be 
speculated that the extracellular portions of the Leu-2 (T8) are cleaved to form 
RLeu-2,  leaving  hydrophobic  fragments  behind  on  the  cell  membrane.  The 
specific cleavage envisioned here suggests the presence of a cell surface enzyme. 
Leu-2 (T8) has been associated with recognition of class I MHC molecules (1, 
4, 21). Its release suggests some immunoregulatory role for RLeu-2. Lyt-2-Lyt- 
3 is not known to be released.  However, class I  H-2-related molecules recently 
were found in mouse serum (22, 23). These H-2 molecules secreted from mouse 
liver have a  mol wt of 40,000, which is smaller than  that of the classical class I 
H-2  molecule  (23).  The  secretion  mechanism  of the  truncated  H-2  antigen 
appears  significantly  different  from  that  of the  release  of the  Leu-2  antigen. 
However, the release of members of this important  immunological recognition 
system in mouse and man may point to the existence of a previously unrecognized 
immunoregulatory mechanism. 
Summary 
We recently have found that the human T  cell antigen  Leu-2 was specifically 
released  from  Leu-2-bearing  cells.  The  preliminary  study  showed  that  the 
released Leu-2 (RLeu-2) from HPB-ALL cells was composed of a single polypep- 
tide  chain  of 27,000  molecular  weight  (mol  wt),  which  was  smaller  than  the 
subunit of the homodimeric molecule found on the cell surface. In the present 
study,  RLeu-2  was  further  characterized  and  compared  with  cellular  Leu-2 
(CLeu-2).  Metabolically radiolabeled  Leu-2  was released  from  HPB-ALL cells 
and this released Leu-2 molecule had a  tool wt of 27,000.  Cell surface radioio- 
dinated HPB-ALL cells were found to release radioactive Leu-2 molecules and 
this antigen also had the same mol wt of 27,000. In both experiments, the CLeu- 
2 was reconfirmed to be composed of a  33,000-mol wt subunit under reducing 
conditions. These experiments establish that the 27,000-mol wt single polypep- 
tide chain of Leu-2 released from the cell is derived directly from the homodi- 
meric  Leu-2 molecule on the cell surface,  presumably by a  specific proteolytic 
cleavage. 
Two-dimensional gel analysis showed that CLeu-2 exhibited extensive charge 
heterogeneity with predominantly  basic isoelectric points,  whereas RLeu-2 was 
a group of more acidic proteins with less charge heterogeneity. Although CLeu- FUJIMOTO  ET  AL.  123 
2  and  RLeu-2  showed  several  different  immunochemical  characteristics,  the 
homology between  these two antigens  was  confirmed by the  following results: 
CLeu-2  and  RLeu-2  were  found  to  share  at  least  three  different  antigenic 
determinants, Leu-2a and Leu-2b, and those which were detected by a polyvalent 
rabbit  antiserum.  Significant  similarities  between  CLeu-2  and  RLeu-2  were 
demonstrated by peptide mapping analysis of these antigens. Therefore, RLeu- 
2 appears to be the specific, physiological product of the CLeu-2 protein. 
The authors wish  to thank  Dr.  Shoshana  Levy for helpful discussion  throughout this 
work. 
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